−0.31USD
−83.99 MUSD
2.39 BUSD
111.72 M
About Amneal Pharmaceuticals, Inc.
Sector
Headquarters
Bridgewater
Employees (FY)
7.85 K
Website
Founded
2002
ISIN
US03168L1052
FIGI
BBG00462PGG0
Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog. It operates through the following segments: Generics, Specialty, and AvKARE. The Generics segment relates to oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, and transdermal patches and topicals. The Specialty segment refers to the development, promotion, sale, and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical, and surgical products and services to governmental agencies. The company was founded by Chirag K. Patel and Chintu Patel in 2002 and is headquartered in Bridgewater, NJ.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of AMRX is 5.46 USD — it has increased by 0.18% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Amneal Pharmaceuticals, Inc. stocks are traded under the ticker AMRX.
Amneal Pharmaceuticals, Inc. is going to release the next earnings report on May 3, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Amneal Pharmaceuticals, Inc. has a max estimate of 8.00 USD and a min estimate of 6.25 USD.
AMRX earnings for the last quarter are 0.19 USD whereas the estimation was 0.13 USD which accounts for 49.84% surprise. Estimated earnings for the next quarter are 0.09 USD. See more details about Amneal Pharmaceuticals, Inc. earnings.
Amneal Pharmaceuticals, Inc. revenue for the last quarter amounts to 620.04 M USD despite the estimated figure of 602.60 M USD. In the next quarter revenue is expected to reach 634.96 M USD.
Yes, you can track Amneal Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, AMRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Amneal Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 7.85 K employees. See our rating of the largest employees — is Amneal Pharmaceuticals, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Amneal Pharmaceuticals, Inc. EBITDA is 492.44 M USD, and current EBITDA margin is 20.57%. See more stats in Amneal Pharmaceuticals, Inc. financial statements.